Nexalin Technology, Inc. (NXLIW)
USD 0.17
(20.14%)
USD 0.17
(20.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -5.69 Million USD | -242.73% |
| 2022 | -1.83 Million USD | 72.4% |
| 2021 | -5.99 Million USD | -84.72% |
| 2020 | -3.32 Million USD | -122.29% |
| 2019 | -1.46 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.29 Million USD | -20.74% |
| 2024 Q1 | -1.07 Million USD | 34.0% |
| 2023 Q4 | -1.62 Million USD | 31.64% |
| 2023 FY | - USD | -242.73% |
| 2023 Q3 | -2.37 Million USD | -171.31% |
| 2023 Q2 | -874.97 Thousand USD | -12.53% |
| 2023 Q1 | -777.55 Thousand USD | -8.59% |
| 2022 Q2 | -422.05 Thousand USD | -12.55% |
| 2022 Q1 | -374.98 Thousand USD | 35.05% |
| 2022 FY | - USD | 72.4% |
| 2022 Q4 | -716.04 Thousand USD | -473.69% |
| 2022 Q3 | -124.81 Thousand USD | 70.43% |
| 2021 Q3 | -1.79 Million USD | 13.75% |
| 2021 FY | - USD | -84.72% |
| 2021 Q4 | -577.35 Thousand USD | 67.84% |
| 2021 Q2 | -2.08 Million USD | -33.11% |
| 2021 Q1 | -1.56 Million USD | -319.52% |
| 2020 Q2 | -1.07 Million USD | 0.0% |
| 2020 FY | - USD | -122.29% |
| 2020 Q4 | -372.75 Thousand USD | 49.37% |
| 2020 Q3 | -736.28 Thousand USD | 31.47% |
| 2020 Q1 | -1.07 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 57.796% |
| Cerus Corporation | -26.53 Million USD | 78.55% |
| OrthoPediatrics Corp. | -8.38 Million USD | 32.084% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 45.762% |
| Talis Biomedical Corporation | -66.04 Million USD | 91.382% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 65.865% |
| Inogen, Inc. | -45.67 Million USD | 87.539% |
| Spectral AI, Inc. | -12.26 Million USD | 53.58% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 88.065% |
| CVRx, Inc. | -38.73 Million USD | 85.304% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -61.339% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 52.986% |
| Orthofix Medical Inc. | -86.98 Million USD | 93.456% |
| Venus Concept Inc. | -26.11 Million USD | 78.202% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 88.564% |
| Bioventus Inc. | -23.07 Million USD | 75.327% |
| BrainsWay Ltd. | -2.31 Million USD | -146.302% |
| Envoy Medical, Inc. | -18.23 Million USD | 68.79% |
| electroCore, Inc. | -17.76 Million USD | 67.95% |
| IceCure Medical Ltd | -15.25 Million USD | 62.682% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 88.559% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 66.231% |
| MaxCyte, Inc. | -44.12 Million USD | 87.101% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 51.582% |
| PAVmed Inc | -75.74 Million USD | 92.485% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 89.412% |
| RxSight, Inc. | -41.03 Million USD | 86.129% |
| Sight Sciences, Inc. | -49.41 Million USD | 88.481% |
| SI-BONE, Inc. | -34.44 Million USD | 83.475% |
| TELA Bio, Inc. | -40.63 Million USD | 85.992% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 90.236% |
| Treace Medical Concepts, Inc. | -39 Million USD | 85.408% |
| LivaNova PLC | 39.01 Million USD | 114.589% |
| 908 Devices Inc. | -34.02 Million USD | 83.271% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 94.853% |
| Nemaura Medical Inc. | -7.28 Million USD | 21.888% |
| NeuroPace, Inc. | -22.83 Million USD | 75.072% |
| LENSAR, Inc. | -8.71 Million USD | 34.679% |
| Apyx Medical Corporation | -18.11 Million USD | 68.573% |
| Cutera, Inc. | -136.56 Million USD | 95.832% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -68.404% |
| BioSig Technologies, Inc. | -28.15 Million USD | 79.78% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 326.234% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 72.881% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.484% |
| Axonics, Inc. | 7.77 Million USD | 173.21% |
| Outset Medical, Inc. | -153.78 Million USD | 96.299% |
| IRIDEX Corporation | -7.44 Million USD | 23.576% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 94.197% |
| IRadimed Corporation | 20.8 Million USD | 127.365% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 29.397% |
| INVO Bioscience, Inc. | -6.88 Million USD | 17.267% |
| Telesis Bio, Inc. | -40.49 Million USD | 85.943% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 115.519% |
| Varex Imaging Corporation | 67.2 Million USD | 108.47% |
| Quipt Home Medical Corp. | 44.07 Million USD | 112.916% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 47.635% |
| Pulmonx Corporation | -55.09 Million USD | 89.668% |
| Dynatronics Corporation | -976 Thousand USD | -483.196% |
| Modular Medical, Inc. | -17.1 Million USD | 66.719% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 60.704% |
| Semler Scientific, Inc. | 23.58 Million USD | 124.13% |
| InMode Ltd. | 196.28 Million USD | 102.9% |
| Bruker Corporation | 599 Million USD | 100.95% |
| Cytosorbents Corporation | -28.81 Million USD | 80.243% |
| DexCom, Inc. | 916.7 Million USD | 100.621% |
| Align Technology, Inc. | 799.03 Million USD | 100.712% |
| Viveve Medical, Inc. | -20.61 Million USD | 72.392% |
| ZimVie Inc. | 91.07 Million USD | 106.25% |
| Movano Inc. | -29.12 Million USD | 80.457% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -29.13% |
| Nexalin Technology, Inc. | -5.69 Million USD | -0.0% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -61.339% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 97.076% |
| Profound Medical Corp. | -27.12 Million USD | 79.014% |
| Insulet Corporation | 323.6 Million USD | 101.759% |
| enVVeno Medical Corporation | -25.01 Million USD | 77.248% |
| Surmodics, Inc. | 1.18 Million USD | 579.128% |
| iCAD, Inc. | -6.56 Million USD | 13.297% |
| Nuwellis, Inc. | -16.35 Million USD | 65.199% |
| Biotricity, Inc. | -8.82 Million USD | 35.525% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 94.124% |
| Aethlon Medical, Inc. | -11.84 Million USD | 51.962% |
| InspireMD, Inc. | -20.91 Million USD | 72.78% |
| PAVmed Inc. | -75.74 Million USD | 92.485% |
| BIOLASE, Inc. | -15.13 Million USD | 62.401% |
| Beyond Air, Inc. | -59.03 Million USD | 90.358% |
| FONAR Corporation | 28.25 Million USD | 120.148% |
| AxoGen, Inc. | -13.32 Million USD | 57.293% |
| Vivani Medical, Inc. | -26.6 Million USD | 78.608% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 123.194% |
| Inari Medical, Inc. | 7.11 Million USD | 180.023% |
| UFP Technologies, Inc. | 72.74 Million USD | 107.825% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -68.116% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 7.537% |
| Tenon Medical, Inc. | -15.52 Million USD | 63.343% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 62.714% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 86.276% |
| AdaptHealth Corp. | -171.09 Million USD | 96.673% |
| Sintx Technologies, Inc. | -6.6 Million USD | 13.757% |
| NanoVibronix, Inc. | -3.43 Million USD | -65.707% |
| Quanterix Corporation | -38.08 Million USD | 85.056% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 47.635% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 19073.473% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.947% |
| TransMedics Group, Inc. | -7.6 Million USD | 25.134% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 73.848% |
| NeuroMetrix, Inc. | -7.09 Million USD | 19.783% |
| Hyperfine, Inc. | -47.06 Million USD | 87.905% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 90.238% |
| Biomerica, Inc. | -5.99 Million USD | 5.022% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1286.9% |
| AVITA Medical, Inc. | -39.56 Million USD | 85.614% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 37.947% |
| Silk Road Medical, Inc | -45.08 Million USD | 87.373% |